ESC Congress 2017

26 - 30 August 2017, Barcelona - Spain

Session Details

Cardiac amyloidosis
Tue 29 Aug 15:35 - 16:25 Cardiomyopathies Moderated Posters Moderated poster station - Poster Area
Chairpersons: Michael ARAD (Ramat Gan, Israel)
Learning Objectives: Moderated Posters are on display from 14:00 to 18:00 on the plasma screen of the topic related Moderated Poster station. During the moderated poster session (15:35-16:25), from a large plasma screen, Presenters will summarise their research within 3 minutes and then address questions from the Chairpersons and Audience.

Access slides, videos, reports online via ESC Congress 365 Other resources

List of Presentations

Related documents
15:35P5842Comparison of various non-invasive tools for diagnosing AL cardiac amyloidosis.Martin NICOL (Paris, France)
15:35P5843Investigation of left ventricular function and biomarkers following treatment in patients with light-chain cardiac amyloidosis 
15:35P5844Predictors of progression of light-chain cardiac amyloidosis.Vilen RAMEEV (Moscow, Russian Federation)
15:35P5845Prognosis of patients with cardiac amyloidosis referred in the French cardiac amyloidosis expert center.Thibaud DAMY (Creteil, France)
15:35P5846AG10, an orally available, novel transthyretin (TTR) stabilizer: integrated preclinical evaluation predicts a highly effective treatment for TTR amyloid cardiomyopathyMamoun ALHAMADSHEH (Stockton, United States of America)
15:35P5847Long-term evolution of longitudinal myocardial deformation in the natural history of familial amyloid polyneuropathyGustavo LIMA DA SILVA (Lisbon, Portugal)
15:35P5848Different features of cardiac involvement in patients with AL vs. TTR amyloidosisVladyslav CHUBUCHNYY (Pisa, Italy)